TopFunds

IQVIA

NYSE: IQV

Stock price

258.88 USD

(+0%) TODAY

Life Sciences Tools & ServicesMedical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3.1
0.8
5.9
1.2
1
1.4
5
5.7
7.3
7.5
7.8
9.8%
02Free cash flow per share
3.2
4.6
2.7
3.8
4.2
6.9
11.8
8.3
8.1
11.5
11.8
14.1%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
5,737
6,815
9,702
10,412
11,088
11,359
13,874
14,410
14,984
15,405
16,310
11%
06% Change
-
-
-
-
-
-
-
-
-
-
-
11%
07Cost of revenue
(4,116)
(4,748)
(6,301)
(6,746)
(7,300)
(7,500)
(9,233)
(9,382)
(9,745)
(10,030)
(12,024)
11.3%
08Gross profit
1,621
2,067
3,401
3,666
3,788
3,859
4,641
5,028
5,239
5,375
4,286
10.2%
09% Margin
28.3%
30.3%
35.1%
35.2%
34.2%
34%
33.5%
34.9%
35%
34.9%
26.3%
32.9% A
10Operating expenses
(975)
(1,491)
(2,736)
(2,925)
(3,011)
(3,128)
(3,248)
(3,229)
(3,262)
(3,173)
(1,999)
7.4%
11% of Revenue
(17)%
(21.9)%
(28.2)%
(28.1)%
(27.2)%
(27.5)%
(23.4)%
(22.4)%
(21.8)%
(20.6)%
(12.3)%
(22.8)% A
12Operating Income
646.6
642
719
741
777
731
1,393
1,799
1,977
2,202
2,287
13.5%
13Income tax expense
(159)
(345)
(987)
(59)
(116)
(72)
(163)
(260)
(101)
(296)
(252)
4.7%
14Net Income
387.2
115
1,309
259
191
279
966
1,091
1,358
1,373
1,360
13.4%
15% Margin
6.8%
1.7%
13.5%
2.5%
1.7%
2.5%
7%
7.6%
9.1%
8.9%
8.3%
6.3% A
16Shares Outstanding
125.6
152
222.6
208.2
199.6
195
195
190.6
186.3
183.4
173.5
3.3%
17EPS Basic
3.2
0.8
6
1.3
1
1.5
5.1
5.8
7.4
7.6
7.9
9.6%
18EPS Diluted
3.1
0.8
5.9
1.2
1
1.4
5
5.7
7.3
7.5
7.8
9.8%
19EBITDA
768
849
1,651
1,883
2,001
2,076
2,767
2,909
3,256
3,453
3,464
16.3%
% Margin
13.4%
12.5%
17%
18.1%
18.1%
18.3%
19.9%
20.2%
21.7%
22.4%
21.2%
18.4% A
20Net Interest Income (expense)
(97.5)
(140)
(339)
(406)
(438)
(410)
(369)
(403)
(636)
(623)
(684)
21.5%
21Net Debt / EBITDA
1.9
7.1
5.6
5.4
5.6
5.3
4
4.1
3.8
3.6
4.1
4.6 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
977.2
1,198
959
891
837
1,814
1,366
1,216
1,376
1,702
1,980
7.3%
23Short-term investments
-
40
46
47
62
88
111
93
120
141
161
16.7%
24Accounts receivable
1,200
1,741
2,144
2,463
2,638
2,466
2,609
2,960
3,413
3,240
3,427
11.1%
25Other current assets
232.5
358
405
473
589
722
677
712
687
746
681
11.3%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
2,412
3,337
3,554
3,874
4,126
5,090
4,763
4,981
5,596
5,829
6,249
10%
Non-Current Assets
28Net property, plant & equipment
188.4
406
440
434
954
953
903
863
819
773
823
15.9%
29Long-term investments
85.3
82
78
142
152
162
164
162
239
374
432
17.6%
30Other non-current assets
1,241
17,383
18,774
18,099
18,019
18,359
18,859
19,331
20,027
19,923
22,440
33.6%
31Total Non-Current Assets
1,514
17,871
19,292
18,675
19,125
19,474
19,926
20,356
21,085
21,070
23,695
31.7%
Total Assets
3,926
21,208
22,742
22,549
23,251
24,564
24,689
25,337
26,681
26,899
29,944
22.5%
LIABILITIES
Current Liabilities
32Accounts payable
145.5
250
322
437
2,512
581
621
645
709
736
3,751
38.4%
33Short-term debt
48.5
92
103
100
100
149
91
152
718
1,145
1,840
43.9%
34Other current liabilities
1,400
2,363
2,479
2,997
1,333
3,828
4,529
4,781
5,064
5,076
2,747
7%
35Total Current Liabilities
1,594
2,705
2,904
3,534
3,945
4,558
5,241
5,578
6,491
6,957
8,338
18%
Non-Current Liabilities
36Long-term debt
2,419
7,108
10,122
10,907
11,941
12,755
12,347
12,859
13,178
13,011
14,334
19.5%
37Other non-current liabilities
248.5
2,535
1,358
1,154
1,102
971
1,059
1,135
900
864
642
10%
38Total Non-Current Liabilities
2,668
9,643
11,480
12,061
13,043
13,726
13,406
13,994
14,078
13,875
14,976
18.8%
39Total Liabilities
4,262
12,348
14,384
15,595
16,988
18,284
18,647
19,572
20,569
20,832
23,314
18.5%
SHAREHOLDERS` EQUITY
40Common stock
8.8
10,602
10,782
10,901
11,049
3
3
10,898
3
3
11,378
104.8%
41Retained earnings / (deficit)
(461.6)
(399)
655
807
998
1,277
2,243
3,334
4,692
6,065
7,425
-
42Accumulated other comprehensive income / (loss)
(111.4)
(570)
46
(224)
(311)
(205)
(406)
(727)
(867)
(1,038)
(943)
23.8%
43Noncontrolling interests
228.5
227
249
240
260
279
-
-
-
-
127
(5.7)%
44Total shareholders' equity
(107.1)
8,860
8,358
6,954
6,263
6,280
6,042
5,765
6,112
6,067
6,630
-
45Total Liabilities and shareholders' Equity
3,926
21,208
22,742
22,549
23,251
24,564
24,689
25,337
26,681
26,899
29,944
22.5%
46Total Debt
2,468
7,200
10,225
11,007
12,041
12,904
12,438
13,011
13,896
14,156
16,174
20.7%
47Net Debt
1,491
6,002
9,266
10,116
11,204
11,090
11,072
11,795
12,520
12,454
14,194
25.3%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
387.2
115
1,309
259
191
279
966
1,091
1,358
1,373
1,360
13.4%
49Depreciation & amortization
127.7
289
1,011
1,141
1,202
1,287
1,264
1,130
1,125
1,114
1,144
24.5%
50Share-based compensation expense
37.8
80
106
113
146
95
170
194
217
206
247
20.7%
51Changes in working capital and other assets
(77)
376
(1,456)
(259)
(122)
298
542
(155)
(551)
23
(97)
2.3%
52Net cash flows from operating activities
475.7
860
970
1,254
1,417
1,959
2,942
2,260
2,149
2,716
2,654
18.8%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(78.4)
(164)
(369)
(459)
(582)
(616)
(640)
(674)
(649)
(602)
(603)
22.6%
54Purchases of investments / marketable securities
(11)
(40)
2
(27)
(25)
(11)
(15)
(5)
(83)
(134)
(20)
6.2%
55Proceeds from maturities of marketable securities
2.5
41
2
459
(22)
-
5
-
-
-
2
(2.2)%
56Other investing activities
19.9
1,894
(825)
(783)
(561)
(169)
(1,453)
(1,327)
(871)
(708)
(1,684)
-
57Net cash flows from investing activities
(67)
1,731
(1,190)
(810)
(1,190)
(796)
(2,103)
(2,006)
(1,603)
(1,444)
(2,305)
42.5%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(515)
(1,000)
(2,529)
(1,390)
(949)
(447)
(406)
(1,168)
(992)
(1,350)
(1,311)
9.8%
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
188
(1,313)
2,511
1,015
747
342
70
941
802
553
1,205
20.4%
61Other financing activities
77.8
29
(54)
(77)
(74)
(112)
(899)
(102)
(192)
(81)
(44)
-
62Net cash flows from financing activities
(249.2)
(2,284)
(72)
(452)
(276)
(217)
(1,235)
(329)
(382)
(878)
(150)
(5)%
63Increase (decrease) in cash and cash equivalents
109.8
221
(239)
(68)
(54)
977
(448)
(150)
160
326
278
9.7%
64Cash and equivalents, ending balance
977.2
1,198
959
891
837
1,814
1,366
1,216
1,376
1,702
1,980
7.3%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
397.3
696
601
795
835
1,343
2,302
1,586
1,500
2,114
2,051
17.8%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

IQVIA (IQV) financial statements and performance

Explore IQVIA (IQV) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.